Top 50 Medical VC Funds & Investors in United Kingdom (October 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Scottish Enterprise
VC Fund
|
34 | United Kingdom, United States, Switzerland | Grant, Seed, Venture - Series Unknown | Biotechnology, Software, Health Care | $119k–$8.4M |
|
Parkwalk Advisors
VC Fund
|
30 | United Kingdom, United States, Philippines | Seed, Series A, Series B | Health Care, Biotechnology, Software | $991k–$44M |
|
UK Innovation & Science Seed Fund
VC Fund
|
30 | United Kingdom, United States | Seed, Venture - Series Unknown | Biotechnology, Health Care, Medical | $582k–$5.9M |
|
SFC Capital
VC Fund
|
27 | United Kingdom, United States, Ireland | Seed, Pre-Seed, Venture - Series Unknown | Software, Artificial Intelligence, Information Technology | $123k–$2.5M |
|
Oxford Science Enterprises
VC Fund
|
22 | United Kingdom, United States, Finland | Seed, Series A, Series B | Health Care, Biotechnology, Therapeutics | $1.3M–$168M |
|
Deepbridge Capital
VC Fund
|
21 | United Kingdom, Spain, Australia | Seed, Venture - Series Unknown, Series A | Health Care, Biotechnology, Medical | $142k–$15M |
|
Future Planet Capital
VC Fund
|
18 | United Kingdom, United States, Singapore | Seed, Convertible Note | Biotechnology, Health Care, Software | $670k–$5.1M |
|
Archangels
VC Fund
|
17 | United Kingdom, United States | Venture - Series Unknown, Seed | Software, Health Care, Biotechnology | $867k–$6.3M |
|
Scottish Investment Bank
VC Fund
|
16 | United Kingdom, United States, France | Venture - Series Unknown, Seed, Series A | Software, Biotechnology, Health Care | $199k–$7.5M |
|
Northstar Ventures
VC Fund
|
16 | United Kingdom, United States, Indonesia | Seed, Venture - Series Unknown, Series A | Software, Health Care, Information Technology | $46k–$10M |
|
SOSV
VC Fund
|
15 | United States, India, United Kingdom | Seed, Convertible Note, Pre-Seed | Biotechnology, Health Care, Software | |
|
Oxford Technology Management
VC Fund
|
15 | United Kingdom, United States | Seed, Series A | Biotechnology, Health Care, Software | $33k–$8.5M |
|
Cambridge Innovation Capital
VC Fund
|
15 | United Kingdom, United States, Ireland | Series A, Series B, Seed | Biotechnology, Health Care, Medical | $2M–$73M |
|
AlbionVC
VC Fund
|
15 | United Kingdom, United States, France | Series A, Seed | Software, Artificial Intelligence, Health Care | $2.4M–$19M |
|
Development Bank of Wales
VC Fund
|
15 | United Kingdom, Australia, United States | Seed, Debt Financing, Venture - Series Unknown | Software, Health Care, Manufacturing | $19k–$5.5M |
|
Mercia Fund Managers
VC Fund
|
14 | United Kingdom, United States, Hungary | Seed, Venture - Series Unknown, Series A | Software, Health Care, Biotechnology | $250k–$14M |
|
Empirical Ventures
VC Fund
|
13 | United Kingdom | Seed, Pre-Seed | Biotechnology, Medical, Health Care | $924k–$5.8M |
|
Calculus Capital
VC Fund
|
13 | United Kingdom, United States, Ireland | Venture - Series Unknown, Series A | Biotechnology, Software, Medical | $1.9M–$10M |
|
GM&C Life Sciences Fund
VC Fund
|
13 | United Kingdom, Italy, Germany | Seed, Venture - Series Unknown, Series A | Health Care, Biotechnology, Medical | $94k–$5.8M |
|
IP Group
VC Fund
|
12 | United Kingdom, United States, Australia | Seed, Series A, Series B | Biotechnology, Health Care, Information Technology | $325k–$68M |
|
Business Growth Fund
VC Fund
|
12 | United Kingdom, Ireland, United States | Venture - Series Unknown, Private Equity, Series A | Software, Manufacturing, Information Technology | $3.4M–$22M |
|
Catapult Ventures
VC Fund
|
12 | United Kingdom, United States, Israel | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $150k–$5.6M |
|
Innovate UK
VC Fund
|
12 | United Kingdom, United States, Ireland | Grant, Pre-Seed, Seed | Health Care, Biotechnology, Software | $58k–$3.5M |
|
Praetura Ventures
VC Fund
|
11 | United Kingdom, Australia, Germany | Venture - Series Unknown, Seed | Software, Information Technology, Artificial Intelligence | $261k–$7.2M |
|
SyndicateRoom
VC Fund
|
11 | United Kingdom, United States, India | Seed, Equity Crowdfunding, Pre-Seed | Health Care, Software, Medical | $390k–$2.7M |
|
Mercia Asset Management
VC Fund
|
11 | United Kingdom, United States | Venture - Series Unknown, Series A, Seed | Software, Information Technology, Health Care | $576k–$13M |
|
Newable Private Investing
VC Fund
|
11 | United Kingdom, United States | Seed, Series A | Software, Health Care, Biotechnology | $196k–$5.6M |
|
M Ventures
VC Fund
|
10 | United States, United Kingdom, Switzerland | Series A, Series B, Seed | Biotechnology, Health Care, Therapeutics | $2.4M–$100M |
|
Oxford Capital
VC Fund
|
9 | United Kingdom, United States, France | Seed, Series A | Software, Health Care, Biotechnology | $1.7M–$16M |
|
Foresight Group
VC Fund
|
9 | United Kingdom, United States, Ireland | Venture - Series Unknown, Private Equity, Seed | Software, Information Technology, Manufacturing | $648k–$8.3M |
|
Speedinvest
VC Fund
|
9 | United Kingdom, Germany, Austria | Seed, Series A, Pre-Seed | Software, FinTech, Artificial Intelligence | $411k–$33M |
|
Maven Capital Partners
VC Fund
|
9 | United Kingdom, United States, Germany | Venture - Series Unknown, Seed, Private Equity | Software, Information Technology, Manufacturing | $648k–$15M |
|
The FSE Group
VC Fund
|
9 | United Kingdom, United States, Canada | Debt Financing, Seed, Venture - Series Unknown | Software, Manufacturing, Information Technology | $106k–$5.4M |
|
Nesta Ventures
VC Fund
|
9 | United Kingdom, United States | Venture - Series Unknown, Seed | Biotechnology, Medical Device, Medical | $569k–$22M |
|
Syncona Partners LLP
VC Fund
|
8 | United Kingdom, United States, Switzerland | Series A, Series B, Seed | Biotechnology, Medical, Health Care | $1.9M–$156M |
|
Providence Investment Company Limited
VC Fund
|
8 | United Kingdom | Series A, Series B | Biotechnology, Biopharma, Medical | $2.2M–$30M |
|
SIS Ventures
VC Fund
|
8 | United Kingdom | Seed, Series A, Venture - Series Unknown | Health Care, Biotechnology, Medical | $1.1M–$33M |
|
Forbion Capital Partners
VC Fund
|
8 | United States, United Kingdom, The Netherlands | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $16M–$180M |
|
Wellcome Trust
VC Fund
|
8 | United States, United Kingdom, France | Grant, Series C, Series B | Biotechnology, Health Care, Medical | $1.6M–$127M |
|
Eos
VC Fund
|
8 | United Kingdom, Ireland | Seed, Series A | Biotechnology, Health Care, Medical | $1.5M–$47M |
|
Redbus Ventures
VC Fund
|
7 | United Kingdom, United States, Australia | Seed, Pre-Seed, Series A | Health Care, E-Commerce, Software | $323k–$23M |
|
Google Ventures
VC Fund
|
7 | United States, United Kingdom, Israel | Series A, Series B, Seed | Software, Health Care, Biotechnology | $1.1M–$121M |
|
Hoxton Ventures
VC Fund
|
7 | United Kingdom, United States, Canada | Seed, Series A, Series B | Artificial Intelligence, Software, Health Care | $1.9M–$35M |
|
Eli Lilly
VC Fund
|
7 | United States, United Kingdom, Canada | Series A, Series B, Series C | Biotechnology, Health Care, Medical | $7M–$150M |
|
Crista Galli Ventures
VC Fund
|
7 | United Kingdom, United States, Sweden | Seed, Pre-Seed, Series A | Health Care, Medical, Wellness | $623k–$14M |
|
QUBIS
VC Fund
|
7 | United Kingdom, United States | Seed, Venture - Series Unknown | Health Care, Biotechnology, Medical | $604k–$5.7M |
|
Octopus Ventures
VC Fund
|
7 | United Kingdom, United States, Germany | Series A, Seed, Series B | Software, Health Care, Artificial Intelligence | $2.1M–$48M |
|
Gabriel Investments
VC Fund
|
7 | United Kingdom | Seed, Pre-Seed, Series A | Medical, Biotechnology, Manufacturing | $302k–$4.1M |
|
Salica
VC Fund
|
7 | United Kingdom, United States, Germany | Seed, Secondary Market, Series A | Software, Information Technology, Health Care | $645k–$346M |
|
Kernel Capital
VC Fund
|
7 | Ireland, United Kingdom, France | Seed, Venture - Series Unknown | Software, Information Technology, Health Care | $531k–$12M |
| Access all 1359 VC funds in United Kingdom Medical startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Scotland's business advice, support and funding agency. Explore our products and services to find the right support for your business and apply online today.
Show more...Investment focus
- Industry: Biotechnology, Software, Health Care
- Stage:Grant, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 401
- Round size: Seed $387k–$4.3M; Grant $119k–$4.8M; Venture - Series Unknown $681k–$8.4M
- Lead/follow: 37% lead, 63% follow
Portfolio highlights
- CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
- Calterra — Calterra is an climate-tech firm that uses AI and satellite/drone data to monitor & verify carbon & biodiversity outcomes.
- SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Philippines
Investor stats
- Total investments: 337
- Round size: Seed $991k–$4.9M; Series A $1.6M–$14M; Series B $1.8M–$44M
- Lead/follow: 27% lead, 73% follow
- Last fund: Likely actively investing — fund raised in 2024
Portfolio highlights
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
- MoA Technology — We harness the principles of natural selection to accelerate discovery for better, safer herbicides so farmers can continue to feed the world.
- Quantum Motion — Quantum Motion delivers scalable silicon-based quantum computing using standard semiconductor manufacturing technology.
UKI2S, formally the Rainbow Seed Fund, is an investment fund backed by the government, providing seed funding to science & technology start-ups and SMEs
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States
Investor stats
- Total investments: 150
- Round size: Seed $582k–$5.9M; Venture - Series Unknown $1M–$4.8M
- Lead/follow: 33% lead, 67% follow
- Last fund: May invest from a new fund soon — last raise in 2014
Portfolio highlights
- Zentraxa — NATURE ENGINEERED FOR PURPOSE Through millions of years of evolution, nature has found solutions to the most difficult problems. Inspired by the diversity of nature, we precision engineer bespoke biomaterials to meet the toughest challenges across
- StandardX — StandardX is a deep-tech company building the isotope refinery powered by a scalable, compact particle accelerator platform.
- INTELLIGENT MASS SPEC SOLUTIONS — Intelligent Mass Spec Solutions develops urine-based mass spectrometry and machine learning diagnostics for adrenal cancer.
Discover the UK's leading SEIS Fund, offering tax-efficient investments in innovative startups. Join thousands of savvy investors and raise capital for your business with SFC Capital.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Information Technology
- Stage:Seed, Pre-Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 777
- Round size: Seed $123k–$2M; Pre-Seed $170k–$858k; Venture - Series Unknown $201k–$2.5M
- Lead/follow: 37% lead, 63% follow
- Last fund: May invest from a new fund soon — raised $1.9M in 2019
Portfolio highlights
- SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
- Anemo Labs — We develop highly selective polymer-based sensors to detect gas VOCs in the ppb range, in real-time. We combine custom hardware with Machine Learning to characterize smells
- INTELLIGENT MASS SPEC SOLUTIONS — Intelligent Mass Spec Solutions develops urine-based mass spectrometry and machine learning diagnostics for adrenal cancer.
Oxford Science Enterprises is the university-partnered venture firm. We work with the University of Oxford to build companies that create fundamental technologies: science-based businesses capable of tackling the planet’s toughest problems. We invest in life science, AI and software, healthcare, and deep tech to create companies taking onchallenges like nuclear fusion, quantum computing and developing treatments and cures for infectious diseases. Founded in 2015, we’ve raised over £600M to create a world-class technology ecosystem, and combine our deep experience with a network of investors, entrepreneurs and sector-experts to find co-investment, build businesses, and hire senior management talent.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Therapeutics
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Finland
Investor stats
- Total investments: 206
- Round size: Seed $1.3M–$12M; Series A $6.3M–$45M; Series B $9.1M–$168M
- Lead/follow: 39% lead, 61% follow
- Last fund: Likely still investing — raised $299M in 2022
Portfolio highlights
- ReEmerge — ReEmerge is a medical technology company that specializes in cognitive network restoration therapy.
- MCatalysis — Manufacturing drop-in liquid commodities from distributed hydrocarbon feedstocks below commodity cost with small modular refining.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
Deepbridge is a different kind of investment manager. They work closely with financial advisers and investors to design innovative products, ranging from investment in technology growth companies to asset-backed renewable energy projects. They also partner with innovative and committed management teams to help UK based companies realise theirpotential and become successful leading-edge businesses.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Spain, Australia
Investor stats
- Total investments: 91
- Round size: Seed $142k–$2.4M; Series A $2M–$15M; Venture - Series Unknown $259k–$2.8M
- Lead/follow: 69% lead, 31% follow
- Last fund: Likely still investing — raised $1.4M in 2022
Portfolio highlights
- upLYFT — upLYFT creates next-generation wearable technology that continuously analyses biomechanics and movement biomarkers, giving athletes, clinicians and physiotherapists precise insight into performance, recovery and injury risk.
- GeneralPractice.AI — GeneralPractice.AI - Infusing Artificial Intelligence into the Fabric of General Practice
- Spotlight Pathology — Spotlight Pathology develops decision support tools powered by artificial intelligence (AI) to help in the diagnosis of blood cancers.
Brilliant Ideas. Brilliant People. Brilliant Minds.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note
- Geography: United Kingdom, United States, Singapore
Investor stats
- Total investments: 287
- Round size: Seed $670k–$5.1M
- Lead/follow: 5% lead, 95% follow
- Last fund: Likely still investing — raised $23M in 2022
Portfolio highlights
- Unloq AI — Unloq is a Decision Intelligence Platform that turns your company data and live market signals into governed strategic recommendations. Approved, tracked, measured.
- Nourished — At Nourished we create innovative. personalised nutrition stacks that are truly unique to you. Vegan, waste-free and always made to order.
- K3 Metrology — K3 Metrology is a specialist metrology company commercialising laser‑based 3D coordinate measurement technology developed at the National Physical Laboratory. The company’s platform is designed to provide high‑accuracy, uncertainty‑aware dimensional data in large‑volume industrial environments, supporting inspection and assembly processes inadvanced manufacturing. Its systems integrate into production workflows where traceable measurements are required across complex geometries and large structures. The technology is applied in sectors such as aerospace, defence, and nuclear, where dimensional integrity and process control are critical.
Established in 1992. Archangels is the oldest continuously operating business angel syndicate in the World. Investing in IP-rich tech & life sciences companies in Scotland, UK.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 87
- Round size: Seed $1.3M–$4.1M; Venture - Series Unknown $867k–$6.3M
- Lead/follow: 53% lead, 47% follow
Portfolio highlights
- CSignum — Revolutionising underwater communications with electromagnetic technology for seamless data integration between surface & submerged devices.
- Earth Blox — Earth Blox provides a platform for analyzing geospatial data through a visual interface for environmental and land analysis. The system enables users to build workflows using satellite imagery and other earth observation datasets without requiring extensive coding knowledge. It supports applications such as deforestation tracking, carbonmonitoring, agriculture assessment, and land use analysis.The platform integrates data sources and processing tools to help users generate insights, automate analyses, and export results for reporting or further use. It also allows collaboration across teams by sharing workflows and outputs within a unified environment. Earth Blox supports organizations working with geospatial intelligence by simplifying access to large-scale environmental data and analysis tools.
- iGii — Integrated Graphene enable better products with a revolutionary design for manufacture process producing the world's highest quality pure 3D Graphene Foam, Gii.
Speak with our team, who can help you find sources of finance, engage with funders and secure investment to grow your business.
Show more...Investment focus
- Industry: Software, Biotechnology, Health Care
- Stage:Venture - Series Unknown, Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 287
- Round size: Seed $331k–$3.1M; Series A $1.7M–$7.5M; Venture - Series Unknown $199k–$4.1M
- Lead/follow: 13% lead, 87% follow
- Last fund: May invest from a new fund soon — last raise in 2015
Portfolio highlights
- Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
- IOTech — Discover IOTech Systems. Deploy, manage, and scale AI-driven, data-rich industrial systems at the edge with our open edge data platform.
- Administrate — Manage instructor-led training with Administrate. Plan, schedule, communicate, resolve issues, and report on training operations from one platform.
Northstar Ventures invests venture capital in early and later stage, high growth companies tackling global challenges, focusing on climate tech and healthy ageing.
Show more...Investment focus
- Industry: Software, Health Care, Information Technology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Indonesia
Investor stats
- Total investments: 270
- Round size: Seed $46k–$1.6M; Series A $295k–$10M; Venture - Series Unknown $261k–$3.8M
- Lead/follow: 26% lead, 74% follow
- Last fund: Likely still investing — raised $20M in 2024
Portfolio highlights
- OneClickComply — Automate SOC 2, ISO 27001, Cyber Essentials, and 10+ frameworks. OneClickFix remediates 1,000+ controls automatically. Trusted by 30+ organisations.
- Land Digital — Land Digital is a tech, web design, web creation, content marketing, digital marketing, SEO, and mobile application agency.
- Magnitude Biosciences — Magnitude Biosciences is a biotechnology firm combine experience in ageing research, the nematode C. elegans and automation.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!SOSV is a global, deep tech venture capital firm that operates the HAX and IndieBio startup development programs focused on human and planetary health. SOSV invests $500,000 in startups at their inception as they onboard either HAX or IndieBio for a 4-6 month period designed to accelerate the raise of their next institutional round. SOSV joins thelater rounds of HAX and IndieBio graduates. HAX, based in a 35,000 sq ft facility in Newark, NJ, is equipped with machine tools, 3D printers, chemical, electrical and mechanical engineering labs, as well as on-staff engineering and design experts. SOSV's IndieBio has locations in NYC and San Francisco, both of which offer extensive services and facilities to founders including on-site BSL-2 labs, well equipped lab benches and hoods, and advanced lab equipment, such as chromatography equipment.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Convertible Note, Pre-Seed
- Geography: United States, India, United Kingdom
Investor stats
- Total investments: 1482
- Lead/follow: no public data
Portfolio highlights
- MixRift — MIXRIFT - game developers specialized in Mixed Reality
- unspun — From 3D scan to perfect fitting custom jeans. unspun makes each pair of jeans unique to your actual body and design. On a mission to reduce global carbon emissions by 1%. As seen in Fast Company's World Changing Ideas, Time's Best Inventions, and PopSci's Best of What's New. Welcome to the future of apparel.
- Mesa Quantum — Unlock the potential of chip-scale quantum sensing for enhanced Position, Navigation, And Timing capabilities. Explore Mesa Quantum's practical solutions.
Oxford Technology's SEIS fund and EIS fund enable private investors to access high growth technology startup opportunities and support UK innovation. SEIS and EIS tax reliefs offer downside protection, whilst gains can be tax free.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Software
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 111
- Round size: Seed $33k–$2.2M; Series A $786k–$8.5M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2012
Portfolio highlights
- OrganOx — OrganOx Limited was founded in 2008 to exploit normothermic preservation technology invented by Prof Peter Friend and colleagues and further developed by Prof Constantin Coussios at the University of Oxford.
- CryoLogyx — CryoLogyx Ltd. trading as CryoLogyx registered in England and Wales 13078280. VAT registered 373846855. Our registered office address is CryoLogyx Ltd, The Venture Centre, Sir William Lyons Road, Coventry, CV4 7EZ.
- Metacarpal — Metacarpal design upper-limb prosthetics without compromise. We aim to make the most robust, functional hand prosthesis that people love wearing because it works so effectively and looks so beautiful. Be proud to show your artificial side!
As a team, we have a passion for science and its potential to drive change. Through our expertise and our position in one of the country's most powerful science and technology ecosystems, we're able to identify and support the most promising entrepreneurs in knowledge intensive businesses and help them achieve their vision.With our financial backing and expert guidance, we're excited to enable the pioneers in life sciences and deep tech to create world-leading companies whose unique ideas bring financial success and global impact.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 118
- Round size: Seed $2M–$31M; Series A $2.6M–$73M; Series B $8.2M–$61M
- Lead/follow: 37% lead, 63% follow
- Last fund: Likely actively investing — fresh fund, raised $332M in 2025
Portfolio highlights
- Immutrin — Immutrin is a biotechnology company developing next‑generation antibody therapies designed to clear systemic amyloid deposits and reverse amyloidosis, this company lead asset targets ATTR cardiomyopathy, a severe and progressive form of amyloidosis, and its antibody represents a potential best‑in‑class treatment engineered to selectively andspecifically remove established amyloid fibrils.
- Trent AI — Trent AI creates AI applications and agent security management software. It aids in risk assessment and mitigation in systems utilizing autonomous or semi-autonomous software agents. The company's technology monitors agent activity across APIs, tools, and workflows. It continuously assesses security posture via iterative scanning andcontextual understanding of system architectures.
- TRIMTECH Therapeutics — Transformative treatments for CNS and inflammatory disorders by selectively destroying disease-causing protein aggregates
AlbionVC supports visionary founders and technologies with long-term capital and scale-up know-how. Founded in 1996, it was amongst the first to back leading global success stories such as Booking.com, Egress, Quantexa and Oviva. With £1bn in AUM and over 100 exits successfully realised, it funds venture breakthroughs that drive real outcomes forfounders, investors and society. AlbionVC is the technology investment arm of Albion Capital Group, which is authorised and regulated by the Financial Conduct Authority. For more information please visit: https://albion.vc/
Show more...Investment focus
- Industry: Software, Artificial Intelligence, Health Care
- Stage:Series A, Seed
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 180
- Round size: Seed $2.4M–$12M; Series A $3.9M–$19M
- Lead/follow: 43% lead, 57% follow
Portfolio highlights
- Oshen — Oshen is a technology enterprise that creates miniature autonomous sailboats designed for persistent, wide-area ocean tracking.
- Outerlimit — Outerlimit provides AI security and governance for agentic AI systems, with controls for identity, access, risk assessment, and activity.
- Gravitee — Open Source API Management Platform - Gravitee
Development Bank of Wales is an independent company, providing commercial funding to Welsh SMEs. They invests private and public funds, including EU funds.
Show more...Investment focus
- Industry: Software, Health Care, Manufacturing
- Stage:Seed, Debt Financing, Venture - Series Unknown
- Geography: United Kingdom, Australia, United States
Investor stats
- Total investments: 294
- Round size: Seed $279k–$3M; Debt Financing $19k–$3.7M; Venture - Series Unknown $383k–$5.5M
- Lead/follow: 62% lead, 38% follow
- Last fund: May invest from a new fund soon — raised $27M in 2018
Portfolio highlights
- nisien.ai — Nisien.ai uses industry-leading AI for the detection, defence and resolution of online harm, for better online safety and digital wellbeing.
- Design and Supply — Design and Supply are specialist manufacturers and suppliers of Industrial Steel Doors and Architectural Products.
- MeOmics Technology — MeOmics Technology is a biotech company with a focus on improving the diagnosis and treatment of mental health illnesses. The company operates in the manufacturing industry and has a team of 9 employees. The team includes experts in Neuronal Cell Biology and Neuropsychopharmacology. The company's mission is to leverage technology to enhancethe understanding and treatment of mental health conditions.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Hungary
Investor stats
- Total investments: 148
- Round size: Seed $250k–$2.1M; Series A $1.3M–$14M; Venture - Series Unknown $394k–$5.3M
- Lead/follow: 68% lead, 32% follow
- Last fund: May invest from a new fund soon — last raise in 2013
Portfolio highlights
- Ben — Ben is the all-in-one platform for any company to personalise benefits and reward.Our secret? Marrying a modern software (SaaS) platform with per-employee Mastercards and financial infrastructure. That’s how Ben instantly adds employee choice to your existing benefits, unlocks access to hundreds of additional options through Ben Card, all whilesaving you time and money.
- Distil.ai — Distil.ai is a software platform that helps businesses to understand their customers’ behavior and identify buying signals.
- MRC Engineering — MRC Engineering Providing a different option to the UK Rail Industry for Telecoms Design. Nationally renowned design specialists who provide extraordinary ...
Empirical Ventures is a specialist VC and venture builder backing the world's boldest early-stage deep-tech and life-science companies, built by scientists.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed
- Geography: United Kingdom
Investor stats
- Total investments: 40
- Round size: Seed $924k–$5.8M; Pre-Seed $1.1M–$1.6M
- Lead/follow: 33% lead, 67% follow
- Last fund: Likely still investing — raised $10M in 2024
Portfolio highlights
- OutSee — We are well-versed in a variety of genomics, AI and cohort analysis techniques. We are also bioinformatics generalists and work with just about any ...
- BoobyBiome — BoobyBiome harnesses breast milk microbiome science to develop products to improve infant health
- Optera — Optera are a leading specialist structural repair company located in the West Midlands, which provides the ideal base for giving national coverage. Optera offer specialist structural solutions to problems widely encountered within the domestic property sector and are engaged daily to provide solutions to the Insurance market place.
At Calculus Capital they are specialists in creating and managing tax efficient private equity funds for the individual. Funds that are ideal for today's market - offering generous tax benefits, and significant growth potential within a sensible risk profile.They look to make £2-5 million investments in established companies with provenmanagement teams and a successful product or service. Their entrepreneurial flair, combined with their experience and sound commercial judgement has resulted in a diversified investment portfolio and an impressive track record. In June 2013 Calculus Capital was top ranked in the prestigious Martin Churchill Tax Efficient Review for the 6th year in a row. The Government has recently shown its support for EIS funds, by maintaining the five generous tax benefits and widening the scope of EIS investments. These changes benefit Calculus Capital's rigorous and proven strategy. As a result they are experiencing their strongest pipeline of prospective investments yet.
Show more...Investment focus
- Industry: Biotechnology, Software, Medical
- Stage:Venture - Series Unknown, Series A
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 80
- Round size: Series A $2.5M–$10M; Venture - Series Unknown $1.9M–$7.8M
- Lead/follow: 65% lead, 35% follow
- Last fund: Likely still investing — fund raised in 2024
Portfolio highlights
- Edify Systems — The Human-First AI platform for multi-site food and beverage operators. Tighter margins, less waste, more time on the floor.
- Grateful — Grateful provides cashless tipping and trunk management software that integrates QR/NFC, EPOS systems, and compliance reporting.
- Resurrect Bio — Resurrect Bio is a disease resistance trait discovery company. Using AI and our high-throughput in planta screening platform we provide traits for breeders.
The GM&C Life Sciences Fund is a seed and early stage venture capital fund targeting life sciences businesses located in the Greater Manchester and Cheshire & Warrington region. The Fund is managed by Catapult Venture Managers ("Catapult Ventures").The Fund is based at Alderley Park, which is well recognised as a site ofnational importance, being the largest life sciences campus of its kind in the UK with more than 500,000 sq. ft. of top-end laboratory and related space and facilities. Until recently, the Park was the R&D headquarters for AstraZeneca.Since 2002, Catapult Ventures has backed a significant number of companies across a broad range of life sciences, including therapeutics (such as Abzena and Oxford BioTherapeutics), medical devices (such as Monica Healthcare and Probe Scientific), contract research organisations (such as R5 Pharmaceuticals and FDAS), diagnostics developers (such as Lumora and Biofortuna), as well as developers of technology used in healthcare applications (such as Oxford Cryosystems and Accutronics). The Fund is the result of a collaboration between Cheshire and Warrington Enterprise Partnership, Greater Manchester Combined Authority, Cheshire East Council, and Manchester Science Partnerships.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown, Series A
- Geography: United Kingdom, Italy, Germany
Investor stats
- Total investments: 36
- Round size: Seed $94k–$1.9M; Series A $1.9M–$4.2M; Venture - Series Unknown $4.3M–$5.8M
- Lead/follow: 64% lead, 36% follow
Portfolio highlights
- ScubaTx — ScubaTx is a breakthrough organ preservation device organ transplant. The ScubaTx device will leverage world-leading expertise in software design to commercialise a proven but unexploited organ preservation technique, Persufflation. ScubaTx will offer healthcare providers significant net savings, an
- Infex Therapeutics — Infex Therapeutics acquires, develops and licenses innovative drugs to treat pandemic infections
- Monument Therapeutics — Monument Therapeutics is a biotechnology company intended to develop drugs to treat serious diseases of the central nervous system.
IP Group's core business is the creation of value for its shareholders and partners through the commercialisation of intellectual property originating from research intensive institutions. Their strength lies in managing this process from finding suitable intellectual property to commercialise to either helping develop businesses and createvalue out of them, or identifying and establishing appropriate commercial partnerships to do so. IP Group's extensive expertise in this area combined with its inside knowledge of both industry and finance have enabled the group to create a formidable track record of consistently delivering excellent results for their companies, for their partners and for their shareholders.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Information Technology
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 231
- Round size: Seed $325k–$7.6M; Series A $2.4M–$30M; Series B $7.9M–$68M
- Lead/follow: 22% lead, 78% follow
- Last fund: Likely actively investing — fresh fund, raised $50M in 2026
Portfolio highlights
- Eight19 — Eight19, located in Cambridge, UK, develops and manufactures plastic photovoltaics for energy harvesting, for the internet of things and for off-grid applications. Through the innovative use of industry-standard, high-volume, roll-to-roll processes and solution-based organic photoactive materials, the company has a highly cost-effective route forscaling-up its technology to supply the largest markets. Eight19 is currently producing modules on a small scale for commercial partners with applications in indoor energy harvesting for wireless sensor and controllers, signage and display, and outdoor power for portable electronics. Our plastic PV modules benefit from flexibility, thinness, light-weight and robustness.
- MAKO — Solving human problems with nature’s surfaces.
- Mach42 — Machine Discovery is a University of Oxford spin-out commercializing new machine learning technology. We leverage proprietary neural network technology to accelerate expensive calculations — and we do it with minimal data and 99.9% fidelity.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!BGF is the most active equity investor in the UK and Ireland, providing long-term, minority investment to growing companies.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Venture - Series Unknown, Private Equity, Series A
- Geography: United Kingdom, Ireland, United States
Investor stats
- Total investments: 605
- Round size: Series A $4.1M–$21M; Private Equity $6.4M–$22M; Venture - Series Unknown $3.4M–$16M
- Lead/follow: 86% lead, 14% follow
- Last fund: Likely still investing — raised $97M in 2022
Portfolio highlights
- Citrus-Lime — Support notifications from the CitrusLime team. Please note that we don't see tweets sent to this account
- Boost Juice Bars UK — Boost Juice Bars UK offer a range of smoothies and freshly squeezed juice products.
- Thames Card Technology —
The team behind Catapult Ventures are among the most experienced venture capital investors in the UK.Their experience spans a range of sectors from healthcare and pharmaceuticals to luxury consumer brands, manufacturing and software, as well as all stages: from start-ups and pre-revenue IP developers to company floatation and billions of poundsin revenue. Their administration team is equally experienced with each member having more than 10 years experience in a venture capital environment.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Israel
Investor stats
- Total investments: 105
- Round size: Seed $150k–$5.6M; Venture - Series Unknown $370k–$5M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2018
Portfolio highlights
- Path Robotics — We create manufacturing robots that autonomously scan, position, and weld your parts without the need for skilled welders or robot programmers.
- Pickle Robot — We make robots that unload trucks without retrofitting the warehouse
- Anello Photonics — Anello Photonics is a technology company developing a silicon photonic optical gyroscope to navigate, position, and motion track autonomous applications in challenging GPS-jammed and spoofed environments. The company's technology portfolio spans over 28 issued patents, and over 44 pending patents, and includes an AI-based sensor fusion engine.It serves the robotics, defense, construction, agriculture, and autonomous vehicles industries.
Innovate UK is part of the UK Research and Innovation .
Show more...Investment focus
- Industry: Health Care, Biotechnology, Software
- Stage:Grant, Pre-Seed, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 1242
- Round size: Seed $143k–$3.5M; Grant $62k–$1.8M; Pre-Seed $58k–$1.3M
- Lead/follow: 76% lead, 24% follow
Portfolio highlights
- SolarSub — SolarSub is an environmental firm that offers floating solar cooling system.
- 52 North Health — At 52 North we are developing fully-integrated clinical, AI and medical-device based systems.
- Productive Machines — Productive Machines Chatter-free Milling Software Optimization Service for every Machine Shop. Apply our recommended spindle speeds and feed rates to your specific machine settings and make the best part, faster, right first time.
Praetura Ventures has been supporting entrepreneurs with more than money since 2011. Click to find out more about how we can help businesses and investors.
Show more...Investment focus
- Industry: Software, Information Technology, Artificial Intelligence
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, Australia, Germany
Investor stats
- Total investments: 167
- Round size: Seed $655k–$4.5M; Venture - Series Unknown $261k–$7.2M
- Lead/follow: 79% lead, 21% follow
- Last fund: Likely still investing — raised $123M in 2022
Portfolio highlights
- Tended — Tended creates advanced solutions to change how people work and improve employee safety across high-risk industries. Through a combination of wearable technology and behavioural science, Tended's main focus is to drive positive behavioural change, which has proven benefits on both an individual and organisational level.Tended'ssolutions are currently improving safety across industry-leading companies in sectors including construction, manufacturing, utilities and logistics.
- Holdson — Holdson is an electrochemical polishing machine tool supplier aiming to address the issue of inconsistent surface finishes on additive manufactured components.The technology is producing intellectual property through patents, providing a competitive advantage in the advanced machinery industry.
- PEAK:AIO — PEAK:AIO delivers software-defined storage for AI, enabling fast, scalable data infrastructure and optimized GPU utilization.
SyndicateRoom is fintech company made up of data-scientists, investment professionals, software developers and marketers with one mission: to be an early investor in every British startup success story.To do this – and make fund investors money – we don’t try to spot the next Big Thing.Instead, we apply a data-driven model to portfolioconstruction; a repeatable process designed to maximise returns and minimise risk for fund investors. As such, we build startup portfolios that don’t attempt to predict the future; they work to stack the odds in investors’ favour.Our fund, Access EIS, aims to build investors a diversified portfolio of 50+ companies by co‑investing exclusively with some of the UK’s best-performing angel investors.
Show more...Investment focus
- Industry: Health Care, Software, Medical
- Stage:Seed, Equity Crowdfunding, Pre-Seed
- Geography: United Kingdom, United States, India
Investor stats
- Total investments: 152
- Round size: Seed $390k–$2.7M; Pre-Seed $425k–$1.9M; Equity Crowdfunding $390k–$2.5M
- Lead/follow: 8% lead, 92% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- ManaMind — Human-like testing at machine scale. ManaMind delivers fully autonomous QA testing for video games - zero-shot, no code access, infinitely scalable.
- aflo — aflo automates inhaler techniques to improve the management of respiratory conditions.
- Joyvié — Joyvié Health designs medical continence products focused on managing severe faecal incontinence. The company is developing a patent-pending class of non-invasive faecal management briefs that prevent stool from contacting the skin. By separating waste from the body, the underwear aims to lower the risk of skin breakdown and secondary infectionwhile reducing the physical and emotional strain on caregivers. Joyvié Health works with care providers to pilot its products in real-world care environments and gather clinical and user feedback. Its offering is intended for adults with continence needs in institutional and home care settings, and for professionals responsible for continence care. The company also engages with investors and partners to advance product development and clinical evaluation.
Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Venture - Series Unknown, Series A, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 112
- Round size: Seed $576k–$3.2M; Series A $2.2M–$13M; Venture - Series Unknown $659k–$12M
- Lead/follow: 63% lead, 37% follow
- Last fund: May invest from a new fund soon — raised $38M in 2018
Portfolio highlights
- StratoBayes — Automated stratigraphic correlation with quantified uncertainty, built on Bayesian statistical inference.
- Camena Bioscience — Camena Bioscience is a synthetic biology company that develops tools to engineer new synthetic biology applications. It has engineered new nucleic acid synthesis technology which improves the quality and speed of synthesis. Its multi-enzymatic technology takes one approach to DNA, RNA, and XNA synthesis, offering increased accuracy over existingPhosphoramidite synthesis technology.Camena Bioscience was founded in 2016 and is headquartered in Cambridge.
- Warwick Acoustics Ltd — Warwick Acoustics is a UK-based technology company specialising in the development of HighRes Audio solutions for the automotive and headphone markets based on its patented High Precision Electrostatic Laminate technology (HPELs). Their ultra thin, lightweight HPELs deliver audiophile performance across a bandwidth several octaves greater thantraditional moving coil speakers in a form factor that is less than one quarter the weight, and one tenth of the thickness. In addition, HPELs offer designers unparalleled flexibility to shaped and form a speaker to individual design requirements.
Newable exists to power business growth. Our strategy of Buy, Grow, Realise focuses on the regulated B2B market.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States
Investor stats
- Total investments: 106
- Round size: Seed $196k–$3.1M; Series A $1.5M–$5.6M
- Lead/follow: 25% lead, 75% follow
- Last fund: May invest from a new fund soon — last raise in 2019
Portfolio highlights
- Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
- Weldfast — Weldfast is a manufacturer and supplier of welding consumables, abrasives, chemicals, premium gas equipment, and safety products.
- EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
Merck Ventures is the strategic, corporate venture capital arm of Merck. Its mandate is to invest in innovative technologies and products with the potential to significantly impact Merck‘s core business areas. From its headquarters in Amsterdam and offices in the US and Israel we invest globally in transformational ideas driven by greatentrepreneurs. Merck Ventures takes an active role in its portfolio companies and teams up with entrepreneurs and co-investors to translate innovation towards commercial success. Merck Ventures has a significant focus on early-stage investing and company creation including the creation of spin-offs to leverage Merck‘s science and technology base.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Therapeutics
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Switzerland
Investor stats
- Total investments: 188
- Round size: Seed $2.4M–$24M; Series A $5.8M–$50M; Series B $13M–$100M
- Lead/follow: 38% lead, 62% follow
Portfolio highlights
- iOnctura — Our mission is to develop high impact, low disruption therapies that extend healthspan. We do this by disrupting the dynamic interplay at the heart of the
- TwoStep Therapeutics — TwoStep Therapeutics is developing novel tumor-targeting therapeutics for solid tumors.
- Polaris Electro-Optics — Polaris Electro-Optics empowers integrated photonics for communications and computation.
Helping individuals and institutions invest in Venture Capital, Infrastructure and Media companies since 1999.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Seed, Series A
- Geography: United Kingdom, United States, France
Investor stats
- Total investments: 164
- Round size: Seed $1.7M–$3.9M; Series A $3.2M–$16M
- Lead/follow: 31% lead, 69% follow
- Last fund: May invest from a new fund soon — raised $66M in 2015
Portfolio highlights
- Flyttr — Flyttr is the leader in developing and deploying biosecurity countermeasures against critical pest threats that spread disease, threaten food security.
- Scan.com — Use scan.com to find the best medical imaging centers near you Find an MRI scan, CT scan, X-ray Scan, or other diagnostic imaging scan with scan.com.
- Noggin HQ — The next generation of credit referencing is coming. Look busy.
Foresight Group is a listed infrastructure and private equity investment manager which has been managing funds on behalf of institutions and retail clients for more than 35 years. Foresight has over £7.2 billion of assets under management across a number of funds on behalf of some of the world’s largest institutional investors, family offices,private and high net-worth individuals and retail investors. Foresight's investment strategies are underpinned by a strong environmental, social & governance (“ESG”) focus, which increasingly meets the demands of today’s investors and ensures we are consistently working towards creating a sustainable legacy for future generations.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Private Equity, Seed
- Geography: United Kingdom, United States, Ireland
Investor stats
- Total investments: 230
- Round size: Seed $648k–$7.3M; Private Equity $2.1M–$8.3M; Venture - Series Unknown $979k–$6.5M
- Lead/follow: 64% lead, 36% follow
- Last fund: Likely actively investing — fresh fund, raised $120M in 2025
Portfolio highlights
- Vertal — Vertal is a food waste recycling company
- Welding Engineers — Welding Engineers has been in business since 1966 and is a major independent door company specialising in the manufacture, installation, repair and maintenance of all types of Industrial Doors and Shutters, Steel Fabrication, Lift Gates and Shutters, Industrial Roofing and Structural Glazing.
- Industrial Engineering Plastics — Industrial Engineering Plastics delivers specialist thermoplastic fabrication, DW154-compliant ductwork, machining, and plastics distribution
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Speedinvest is a globally active European venture capital firm built on a simple belief: many move more. From six offices across EMEA, our sector-focused investment teams back relentless founders from pre–Seed to Growth with long-term conviction, providing day-one access to our global network of corporate customers, experts, industry leaders, andtop-tier follow-on investors to scale smarter and faster. Building lasting companies like Bitpanda (Austria), Moove (Nigeria), Gigs (U.S.), Tide (UK), ARX Robotics (Germany), Wayflyer (Ireland), GoStudent (Austria), Seqera Labs (Spain), and Cylib (Germany) — together. Big ideas may start with one. But scaling and winning take The Power of More.
Show more...Investment focus
- Industry: Software, FinTech, Artificial Intelligence
- Stage:Seed, Series A, Pre-Seed
- Geography: United Kingdom, Germany, Austria
Investor stats
- Total investments: 674
- Round size: Seed $797k–$7.9M; Pre-Seed $411k–$3.8M; Series A $4.1M–$33M
- Lead/follow: 41% lead, 59% follow
- Last fund: Likely still investing — raised $372M in 2022
Portfolio highlights
- Findery — Find and leave notes anywhere in the world, discover local knowledge, hidden secrets, and exciting stories. Share your travel knowledge, geoblog, or local news!
- GAMINSIDE — GAMINSIDE revolutionizes your relationship with your customers. As European full service provider, we deliver the complete package with solutions, services and software for gamified loyalty that is tailor-made and unique to your products, brands and customers. Integrate the best ideas from gamification and customer loyalty in your business areato exceed your commercial targets with GAMINSIDE.
- Polaron — Material Design. Supercharged with AI.
Maven is one of the UK's leading private equity and investment firms. We provide essential capital and expertise to help businesses unlock their potential.
Show more...Investment focus
- Industry: Software, Information Technology, Manufacturing
- Stage:Venture - Series Unknown, Seed, Private Equity
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 227
- Round size: Seed $783k–$5M; Private Equity $981k–$15M; Venture - Series Unknown $648k–$8.3M
- Lead/follow: 74% lead, 26% follow
- Last fund: May invest from a new fund soon — raised $132M in 2019
Portfolio highlights
- KubeNet — We are KubeNet - a multi-award winning technology solutions provider based in Glasgow. Whether it's Managed IT, IT Support, Cloud, Connectivity, Voice or Cyber Security, we're by your side as your trusted technology partner.
- Tixserve — Secure, Trackable, Interactive Digital Tickets for Live Events
- ReadyGo Diagnostics — ReadyGo Diagnostics has invented a novel “Diagnostic Pen”. Low cost, intuitive to use from the raw sample, the ReadyGo Pen will be a game-changer in the newly emerging consumer diagnostics market, offering a yes/no answer in minutes, based on molecular analysis.
The FSE Group provides growth finance and support for ambitious UK businesses, helping SMEs start, scale and succeed through tailored funding solutions.
Show more...Investment focus
- Industry: Software, Manufacturing, Information Technology
- Stage:Debt Financing, Seed, Venture - Series Unknown
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 277
- Round size: Seed $294k–$2.3M; Debt Financing $106k–$696k; Venture - Series Unknown $485k–$5.4M
- Lead/follow: 75% lead, 25% follow
- Last fund: Likely still investing — raised $88M in 2023
Portfolio highlights
- Spotta — Spotta's smart pest systems help pest control monitor and identify pests. Solutions for hospitality, care homes, agriculture, farming and forestry.
- SageTech — Integrating simply, seamlessly and universally into existing anaesthetic equipment, the practical solution is supported by an easy to use, fully managed...
- Amino —
We bring bold ideas to life to change the world for good.
Show more...Investment focus
- Industry: Biotechnology, Medical Device, Medical
- Stage:Venture - Series Unknown, Seed
- Geography: United Kingdom, United States
Investor stats
- Total investments: 76
- Round size: Seed $569k–$2.2M; Venture - Series Unknown $6M–$22M
- Lead/follow: 9% lead, 91% follow
- Last fund: May invest from a new fund soon — raised $41M in 2014
Portfolio highlights
- Citymart — Citymart powers cities to deliver services that work. Following best practices developed with leading cities around the world, Citymart connects cities and revolutionizes the way cities frame needs, complete procurements, and improve service delivery. Over 100 cities in 35 countries have adopted Citymart tools and methods to-date.
- Featurespace — The Featurespace Platform offers cutting-edge, real-time machine learning solutions to prevent fraud and financial crime. Learn more today.
- Radio Physics Solutions — PASAR123 merupakan landasan utama bandar slot nomor 1 di indonesia memiliki fasilitas slot deposit pulsa tanpa potongan penarikan sangat mudah dan cepat.
Syncona is a FTSE250 company focused on founding, building and funding healthcare companies to deliver transformational treatments to patients in areas of high unmet need.
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Series A, Series B, Seed
- Geography: United Kingdom, United States, Switzerland
Investor stats
- Total investments: 75
- Round size: Seed $1.9M–$17M; Series A $13M–$87M; Series B $29M–$156M
- Lead/follow: 59% lead, 41% follow
Portfolio highlights
- Apini Therapeutics — Apini is a creating novel small chemical two most prevalent types of inflammatory bowel disease.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Re-Aim Therapeutics — Re‑Aim Therapeutics is a UK‑based biotech start‑up developing functional cures for T cell–mediated autoimmune diseases by selectively depleting pathogenic T‑cell subsets. Its lead asset, REA‑001, is a monoclonal antibody designed to potently and precisely eliminate disease‑causing type‑17 T cells, aiming to reset the immune system and achievedurable, treatment‑free remission in multiple autoimmune conditions.
Providence Investment Company
Show more...Investment focus
- Industry: Biotechnology, Biopharma, Medical
- Stage:Series A, Series B
- Geography: United Kingdom
Investor stats
- Total investments: 15
- Round size: Series B $2.2M–$30M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- evonetix — evonetix is a new spin-out company that is currently incubating in the centre of the world-renowned Cambridge cluster of high-tech and life science organisations. We are seeking to develop and commercialise a new approach to the synthesis of DNA to facilitate the fast-emerging and exciting field of synthetic biology. By employing novel techniqueswe are able to advance DNA synthesis to levels never before seen. Our engineering team has decades of experience developing high integrity automated systems. Our high calibre team brings together expertise from across the scientific and engineering disciplines.
- pixlbio (formerly DefiniGEN) — Generate metabolic disease phenotypes in primary-like human cells using the best-in-class human iPSC differentiation platform. Find out more here!
- Cambridge Photon Technology — Cambridge Photon Technology is a developer of organic photovoltaic devices used to enhance next-generation solar technology. Its devices engage in the deployment of off-grid solar power and use advanced nanotechnology to split each incoming blue and green photon into two infra-red photons that enable clients to deploy solar power throughlightweight devices whenever needed.
SIS Ventures has been created with the overall aim of supporting and growing high impact organisations through access to mission-aligned investment. SIS Ventures has a goal of becoming the go to investor and partner for social entrepreneurs. The fund will offer conventional financial returns alongside social and/or environmental returns byinvesting either equity or debt into purpose driven companies.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Series A, Venture - Series Unknown
- Geography: United Kingdom
Investor stats
- Total investments: 33
- Round size: Seed $1.1M–$4.9M; Series A $2.8M–$21M; Venture - Series Unknown $1.6M–$33M
- Lead/follow: 3% lead, 97% follow
- Last fund: May invest from a new fund soon — raised $1.3M in 2018
Portfolio highlights
- Dxcover — Dxcover are a world leader in liquid biopsy and artificial intelligence for early detection of cancers and other diseases to improve survival and quality of life.
- MiAlgae — MiAlgae is a new-age microalgal production company that aims to revolutionize the £340 billion global livestock feed industry by producing microalgal products – through the remediation of wastewater – as nutrient supplements for fishmeal in livestock feeds. Their microalgal products are high in omegas and proteins, both of which are required forthe production of many livestock feeds, especially in the aquaculture sector.Their production methodology uses circular economy to reduce the operating costs involved in the production of microalgae and as such allows them to compete with other supplements currently on the market.
- Solasta Bio — Solasta Bio develops environment-friendly products that meet a global need for new and effective crop protection.
Impacting the future of medicine.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, The Netherlands
Investor stats
- Total investments: 228
- Round size: Series A $19M–$180M; Series B $16M–$155M; Series C $22M–$120M
- Lead/follow: 50% lead, 50% follow
- Last fund: Likely actively investing — fresh fund, raised $606M in 2026
Portfolio highlights
- Sling Therapeutics — Sling Therapeutics is a biopharmaceutical company focused on late-stage development for thyroid eye disease, aspiring to improve the lives of patients and their families.
- Beacon Therapeutics — Beacon aids in restoring and improving the vision of patients with ophthalmic gene therapy. Find out more.
- Lisata Therapeutics — Lisata is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of innovative medicines.
Wellcome Trust is a medical research charity that funds research that aims to protect and improving human and animal health. It focuses on the fields of public engagement, investments, innovation, humanities, and social science. It was founded in 1936 and headquartered in London, England.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Grant, Series C, Series B
- Geography: United States, United Kingdom, France
Investor stats
- Total investments: 126
- Round size: Grant $1.6M–$10M; Series B $18M–$68M; Series C $10M–$127M
- Lead/follow: 40% lead, 60% follow
- Last fund: May invest from a new fund soon — raised $331M in 2018
Portfolio highlights
- Lario Therapeutics — Lario Therapeutics are developing first-in-class disease modifying treatments for severe neurological disorders. Precision Neuroscience Today.
- Wysa — Use Wysa to vent or just talk through negative thoughts and emotions. Let it help you cope with pandemic anxiety and lockdowns. It is anonymous, safe and free.
- Ineffable Intelligence — Making first contact with superintelligence.
Eos invests in, & commercialises, science & technology, from local seed-stage to global scale, with a focus on improving lives.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Seed, Series A
- Geography: United Kingdom, Ireland
Investor stats
- Total investments: 43
- Round size: Seed $1.5M–$11M; Series A $1.6M–$47M
- Lead/follow: 60% lead, 40% follow
Portfolio highlights
- TaiSan — A polymer-electrolyte sodium battery for the e-bike and scooter fleet.
- Bioliberty — Engineering the future of physical and occupational therapy.
- Scarlet Therapeutics — Scarlet Therapeutics is developing the novel red blood cell-based therapeutics (tRBCs) generation platform.
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Redbus Group is a UK based investment group that invests in early stage ventures and funds or acquires businesses that require restructuring. Redbus Group came into existence as an offshoot of Redbus Film Distribution which was founded in 1997 as a film distribution company. Redbus Film Distribution had rapidly established itself as one of thelargest and most profitable film distributors in the UK. In late 2000 it was sold to Helkon Media AG.Redbus through its subsidiary Filmgroup was the first company in Europe to successfully develop technology to compress and stream moving images over the internet. Between 2000 and 2004 Redbus was the UK's fastest growing company with a compound annual growth rate in-excess of 280%. In 2005 Redbus sold its production and distribution operations to Lionsgate Inc and sold its stake in Lovefilm of which it was co-founder, to Amazon in 2010.Employing an entrepreneurial and disciplined approach, Redbus, either with partners or alone looks for opportunities to leverage off its capital, market knowledge and management resources.
Show more...Investment focus
- Industry: Health Care, E-Commerce, Software
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Australia
Investor stats
- Total investments: 153
- Round size: Seed $586k–$5.8M; Pre-Seed $323k–$1.6M; Series A $5.4M–$23M
- Lead/follow: 2% lead, 98% follow
Portfolio highlights
- SOLVE — SOLVE have developed novel transient flow techniques that extend the capabilities of current approaches. SOLVE’s products leverage technology for the efficient collection of data from chemical reactions, as well as predictive computational models tuned based on the collected data. Both the data by itself, as well as the models, are used to informthe reaction conditions and solvent mixtures applied to manufacture chemical compounds at different scales of production.
- Tolemy Bio — The AI-native virtual cell platform for therapeutic development and manufacture.
- Nila Elder Care — Nila acquires independent UK homecare agencies and runs them on our AI platform. Families get care they can count on; owners get a fair exit and a team that's looked after.
GV supports innovative founders moving the world forward.
Show more...Investment focus
- Industry: Software, Health Care, Biotechnology
- Stage:Series A, Series B, Seed
- Geography: United States, United Kingdom, Israel
Investor stats
- Total investments: 1508
- Round size: Seed $1.1M–$16M; Series A $6M–$100M; Series B $15M–$121M
- Lead/follow: 30% lead, 70% follow
- Last fund: May invest from a new fund soon — raised $100M in 2014
Portfolio highlights
- Tennr — Tennr is a custom AI assistant that accelerates research, answers complex questions, and generates custom reports.
- ngmoco — ngmoco ("Next Generation MObile COmpany") is creating and producing games for the iPhone. CEO Neil Young is a former executive from Electronic Arts, where he oversaw the development of several hit titles. Another EA vet and partner at Kleiner Perkins, Bing Gordon, sits on the board. Kleiner is an investor through its iFund.
- SolveAI —
Hoxton Ventures focuses on startups that either disrupt existing industries or invent entirely new market categories. Hoxton typically invests between $500,000 and $5 million into pre-seed, seed, and Series A stage companies, and follows its capital through the life of the company. The firm is based in London and invests all across Europe.
Show more...Investment focus
- Industry: Artificial Intelligence, Software, Health Care
- Stage:Seed, Series A, Series B
- Geography: United Kingdom, United States, Canada
Investor stats
- Total investments: 141
- Round size: Seed $1.9M–$12M; Series A $5M–$28M; Series B $6M–$35M
- Lead/follow: 43% lead, 57% follow
- Last fund: Likely actively investing — fresh fund, raised $60M in 2026
Portfolio highlights
- Preply — Looking for a tutor? Preply is the best platform for private online lessons with a flexible payment system and affordable prices. Book your first lesson.
- Veridion — Veridion is a living digital replica of the business world. Decision-grade data for enterprise scale systems
- Fabrica AI — Fabrica AI offers a revolutionary platform for faster robot development, using custom hardware designs and learned optimal control to increase efficiency while minimizing complexity and cost. With a vision for a future where robot development takes days, not years.
Lilly is a medicine company that puts health above all. Learn about our medicines, view condition support, find care, and much more.
Show more...Investment focus
- Industry: Biotechnology, Health Care, Medical
- Stage:Series A, Series B, Series C
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 152
- Round size: Series A $7M–$94M; Series B $11M–$150M; Series C $11M–$107M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Thatch — Thatch is an all-in-one platform that makes it easy to offer the most personalized healthcare experience to your employees using an ICHRA.
- Circle Pharma — Circle Pharma is an early-stage biotechnology company applying proprietary computational design algorithms and innovative chemistry to develop cell-permeable macrocycle peptide therapeutics against important clinical targets. It does this through an iterative, rational design process that deploys large virtual libraries of conformationally diversemacrocycle scaffolds selected for inherent permeability. The company was founded by Matt Jacobson and Scott Lokey in 2012 and is headed by David J. Earp.
- BigHat Biosciences — We use machine learning and synthetic biology to design and engineer antibody therapeutics.
Physician-led venture capital investing in TechBio, DeepTech Healthcare, and Digital Health.
Show more...Investment focus
- Industry: Health Care, Medical, Wellness
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom, United States, Sweden
Investor stats
- Total investments: 37
- Round size: Seed $960k–$9.2M; Pre-Seed $623k–$2.5M; Series A $5.7M–$14M
- Lead/follow: 3% lead, 97% follow
Portfolio highlights
- Jude — Science-backed food supplement that makes you feel empowered, not embarrassed.
- Vitrue Health — At Vitrue Health, our mission is to reduce or eliminate the impact that musculoskeletal health issues have on over 40% of the population using cutting edge technology. We believe that the foundation of successful outcomes in musculoskeletal health, at every stage of the pathway, is accurate assessment. Whether it's a desk worker with early stages of neck pain or a patient having a total knee replacement, Vitrue's technology can help.
- Collective Minds — Collective Minds develops and delivers a cloud-based collaboration platform for healthcare and research with access to data, human and digital expertise.
Working with academic entrepreneurs, QUBIS Ltd has grown a portfolio of shareholdings in viable companies over 27 years that have succeeded on an international level.
Show more...Investment focus
- Industry: Health Care, Biotechnology, Medical
- Stage:Seed, Venture - Series Unknown
- Geography: United Kingdom, United States
Investor stats
- Total investments: 39
- Round size: Seed $604k–$2.6M; Venture - Series Unknown $1.3M–$5.7M
- Lead/follow: 15% lead, 85% follow
Portfolio highlights
- aflo — aflo automates inhaler techniques to improve the management of respiratory conditions.
- StimOxyGen — Improving cancer outcomes by overcoming hypoxia.
- AMPLY Discovery — AMPLY Discovery is to develop new biological molecules for anti-infective health and nutrition applications in animal and human health.
We provide venture capital investment for the people, ideas and industries that will change the world. Learn about what we do and the kind of founders we back.
Show more...Investment focus
- Industry: Software, Health Care, Artificial Intelligence
- Stage:Series A, Seed, Series B
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 387
- Round size: Seed $2.1M–$13M; Series A $3.2M–$21M; Series B $7.5M–$48M
- Lead/follow: 57% lead, 43% follow
- Last fund: May invest from a new fund soon — raised $101M in 2019
Portfolio highlights
- Turtl — Create personalized interactive content experiences that excite, engage and convert your audience with Turtl's intuitive content software.
- Sprout.ai —
- Minimum — Take control of your organization's carbon accounting and management with granular, robust and auditable emissions data.
Gabriel Investments opens the door to new businesses, quickly and simply.
Show more...Investment focus
- Industry: Medical, Biotechnology, Manufacturing
- Stage:Seed, Pre-Seed, Series A
- Geography: United Kingdom
Investor stats
- Total investments: 22
- Round size: Seed $302k–$2M; Pre-Seed $407k–$564k; Series A $803k–$4.1M
- Lead/follow: 23% lead, 77% follow
Portfolio highlights
- Mirna — Soon to be launched, our AI-powered MI:RNA platform is designed to detect a range of diseases prior to the development of clinical signs. This groundbreaking
- Seluna — Seluna is developing medical software to help doctors advance clinical diagnostics for paediatric sleep disorders.
- Regeno Energy — Regeno Resources accelerating the goal of clean energy with inexpensive, self-installing wind turbines.
Founded as an investment firm focusing on the most promising startups, we have evolved into a unique set of private market funds investing globally in equity and debt across complementary sectors and stages. We fuse traditional values with a contemporary approach and balance exacting processes with the agility to capture commercial opportunity andcompelling investment returns. Our continuous search for new opportunities has led us to create a balanced collection of complementary funds and relationships.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Secondary Market, Series A
- Geography: United Kingdom, United States, Germany
Investor stats
- Total investments: 249
- Round size: Seed $645k–$4.3M; Series A $3.9M–$19M; Secondary Market $60M–$346M
- Lead/follow: 28% lead, 72% follow
- Last fund: Likely actively investing — fresh fund, raised $12M in 2026
Portfolio highlights
- Moneybox — Moneybox is the simple way to save, invest, buy your first home, and combine your old pensions - all with one award-winning app. Download now.
- CameraMatics — Digitize fleet management to optimize performance. Onboard sensors, smart cameras, & apps to mitigate risk, manage safety & achieve sustainability goals.
- Modern Milkman — Modern Milkman is a Yorkshire-based milk delivery company.
Kernel Capital is the independent manager of The Bank of Ireland Kernel Capital Venture Funds, one of the largest and most active sources of equity finance on the island of Ireland. Kernel leverage their extensive network to enable their portfolio companies recruit the highest caliber people, to break into new international markets and to generaterevenues of scale. It is the only investment firm with venture capital Funds dedicated to both jurisdictions on the Island. Kernel have raised over €210M from investors which including their strategic partner Bank of Ireland, Invest NI, Enterprise Ireland, Galway University Foundation, The University of Limerick Foundation, The New York State Common Retirement Fund and undisclosed Family Offices. Consistently delivering strong financial returns for their investors Kernel have led more than 20 substantial trade sales to NASDAQ, NYSE, and LSE listed corporations.
Show more...Investment focus
- Industry: Software, Information Technology, Health Care
- Stage:Seed, Venture - Series Unknown
- Geography: Ireland, United Kingdom, France
Investor stats
- Total investments: 96
- Round size: Seed $531k–$2M; Venture - Series Unknown $1.2M–$12M
- Lead/follow: 51% lead, 49% follow
- Last fund: May invest from a new fund soon — raised $40M in 2013
Portfolio highlights
- Cirdan — Cirdan provides highly reliable, innovative LIS & imaging solutions for the acceleration & enhancement of diagnosis, optimized for pathology & clinical lab.
- preico — Preico Network empowers Web2 and Web3 developers to create, own, and monetize crypto-native AI models on a decentralized platform
- Pretto — Pretto is the only truly transparent online real estate price comparator.Pretto accompanies you until the signing of your loan, free of charge and without commitment.
Medical VC funding in United Kingdom at a glance
Stats across 1.8k deals from 1.4k investors.
Access all 1359 VC funds in United Kingdom Medical startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Medical VC Funds in United Kingdom investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 1359 VC funds investing in United Kingdom Medical startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!